BioCardia, Inc. Notes Payable, Current
BioCardia, Inc. (BCDA) had Notes Payable, Current of $284.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current
us-gaap:NotesPayableCurrent · last filed 2020-11-10
- 2020-09-30: Notes Payable, Current $284.00K.
- 2020-06-30: Notes Payable, Current $226.00K.
| Period end | Notes Payable, Current |
|---|---|
| 2020-09-30 | $284.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $226.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |